Detection of Residual/Recurrent cervical disease after successful LEEP conization: The possible role of mRNA-HPV test

Current Pharmaceutical Design

Volumn 19, Issue 8, 2013, Pages 1450-1457

  Zappacosta, Roberta ^a   Ianieri, Manuel Maria ^b   Tinelli, Andrea ^c   Gustapane, Sarah ^b   D'Angelo, Chiara ^a   Pia Gatta, Daniela Maria ^a   Capanna, Serena ^a   Rosini, Sandra ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Cardiology Department SS Annunziata Hospital   (Italy)

^c VITO FAZZI HOSPITAL   (Italy)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasm; Genome amplification; Human papillomavirus; LEEP; Loop electrosurgical excision procedure; mRNA HPV; REAL Time PCR

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER RISK; CANCER THERAPY; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LOOP ELECTROSURGICAL EXCISION PROCEDURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT FAILURE; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

EID: 84876725614     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319080012     Document Type: Article

References (35)

1. Martin CM, O'Leary JJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet Gynaecol 2011; 25: 605-15.
2. Bruinsma FJ, Quinn MA. The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis. BJOG 2011; 118: 1031-41.
3. Armarnik S, Sheiner E, Piura B, Meirovitz M, Zlotnik A, Levy A. Obstetric outcome following cervical conization. Arch Gynecol Obstet 2011; 283: 765-9.
4. Costa S, De Nuzzo M, Infante FE, et al. Disease persistence in patients with cervical intraepithelial neoplasia undergoing electrosurgical conization. Gynecol Oncol 2002; 85: 119-24.
5. Nam K, Chung S, Kim J, Bae D. Factors associated with HPV persistence after conisation in patients with negative margins. J Gynecol oncol 2009; 20: 91-95.
6. Kochen M, Helmerhorst TJM, Berkhof J, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study. lancet Oncol 2011; 12: 441-50.
7. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition-summary document. Ann Oncol 2010; 21: 448-58.
8. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008; 19: 342-54.
9. Alonso I, Torné A, Puig-Tintoré LM, et al. Pre-and postconization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecol Oncol 2006; 103: 631-6.
10. Jordan J, Martin-Hirsch P, Arbyn M, et al. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 2009; 20: 5-16.
11. Benchimol Y, Mergui JL, Uzan S. The role of viral HPV testing in post-operative follow-up. In Taylor and Francis Eds. HPV handbook. Current evidence-based applications. New York: Taylor and Francis Group 2005, pp 41-58.
12. Zielinski GD, Rozendaal L, Voorhorst FJ, Berkhof J, Snijders PJF, Risse EJK. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 2003; 91: 67-73.
13. Verguts J, Bronselaer B, Donders G, Arbyn M, Van EJ, Drijkoningen M. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. Int J Obstet Gynaecol 2006; 113: 1303-7.
14. Origoni M, Carminati G, Rolla S, et al. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis 2012; 5: 3-11.
15. Zappacosta R, Rosini S. Cervical Cancer Screening: From Molecular Basis to Diagnostic Practice, Going Through New Technologies. Technol in Cancer Res and Treat 2008;7(3):161-74.
16. Cuschieri, K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev 2008;17:2536-45.
17. Lie AK, Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 2008; 8: 405-15.
18. Schweizer, J., et al 2010. Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer. J Clin Microbiol 2010; 48: 4646-48.
19. Ferenczy A, Choukroun D, Falcone T, Franco E. The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North American experience Am J Obstet Gynecol.1995; 172: 1246-50.
20. Tinelli A, Leo G, Dell'Edera D, et al. Molecular methods for a correct diagnosis of multiple HPV infections and clinical implications for vaccine. Int J Gynecol Cancer 2011; 21: 545-50.
21. Tinelli A, Leo G, Pisanò M, et al. HPV viral activity by mRNAHPV molecular analysis to screen the transforming infections in precancer cervical lesions. Curr Pharm Biotechnol 2009; 10: 767-71.
22. Wu D, Zheng Y, Chen W, et al. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for highgrade cervical intraepithelial neoplasia with negative margins. Aust N Z J Obstet Gynaecol 2011; 51: 114-8.
23. Bae JH, Kim CJ, Park TC, Namkoong SE, Park JS. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer 2007; 17: 1271-7.
24. Verguts J, Bronselaer B, Donders G, et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG 2006; 113: 1303-7.
25. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conisation. Gynecol Oncol 2003; 90: 358-65.
26. Sarian LO, Derchain SF, Pitta Dda R, Morais SS, Rabelo-Santos SH. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 2004; 31: 270-4.
27. Nobbehuis MA, Helmerhorst TJ, van den Brule AJ, Rozendanl L, Voorhorst FJ, Bezemer PD. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001; 358: 1782-3.
28. Beltrami C, Manfredi R, D'Antuono A, Chiodo F, Varotti C. Sexually-transmitted infections in adolescents and young adults in a large city of Northern Italy: a nine-year prospective survey. New Microbiol 2003; 26: 233-41.
29. Ghaem-Maghami S, Sagi S, Majeed G, Soutter WP. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol 2007; 8: 985-93.
30. Dalstein V, Riethemuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP. Persistence and load of high-risk HPVare predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003; 106: 396-403.
31. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 2001; 83: 95-9.
32. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002; 360: 228-9.
33. Frega A, Lorenzon L, Giovagnoli MR, et al. Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age. Int J Immunopathol Pharmacol 2011; 24: 461-70.
34. Zhao C, Kalposi-Novak P, Austin RM. Follow-up findings in young females with high-grade squamous intraepithelial lesion papanicolaou test results. Arch Pathol Lab Med 2011; 135: 361-4
35. Benevolo M, Vocaturo A, Caraceni D, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol 2011; 49: 2643-50.